Public health and physician focused strategies to improve medication adherence in psychotic disorders

World Psychiatry

Volumn 12, Issue 3, 2013, Pages 238-239

  Farooq, Saeed ^a,b  

^a STAFFORDSHIRE UNIVERSITY   (United Kingdom)

^b Postgraduate Medical Institute   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; TUBERCULOSTATIC AGENT;

COST EFFECTIVENESS ANALYSIS; HEALTH CARE ACCESS; HEALTH CARE SYSTEM; HUMAN; LOWEST INCOME GROUP; MEDICATION COMPLIANCE; NOTE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOSIS; PUBLIC HEALTH; SCHIZOPHRENIA; SHORT COURSE THERAPY; TUBERCULOSIS;

EID: 84885113325     PISSN: 17238617     EISSN: 20515545     Source Type: Journal    
DOI: 10.1002/wps.20068     Document Type: Note

References (9)

1. Haynes RB, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews 2008:CD000011.
2. Lora A, Kohn R, Levav I, et al. Service availability and utilization and treatment gap for schizophrenic disorders: a survey in 50 low- and middle-income countries. Bull World Health Organ 2012; 90: 47-54B.
3. Large M, Farooq S, Nielssen O,. Duration of untreated psychosis in low and middle income economies: the relationship between GDP and DUP. Br J Psychiatry 2008; 193: 272-8.
4. World Health Organization. Stop tuberculosis initiative. apps.who.int.
5. Farooq S,. Early intervention for psychosis in low and middle income (LAMI) countries needs a public health approach. Br J Psychiatry 2013; 202: 168-9.
6. Farooq S, Nazar Z, Irfan M, et al. Schizophrenia treatment adherence in resource poor setting: randomised controlled trial of Supervised Treatment in Outpatients for Schizophrenia (STOPS). Br J Psychiatry 2011; 199: 467-72.
7. Kinon BJ, Liu-Seifert H, Adams DH, et al. Differential rates of treatment discontinuation in clinical trials as a measure of treatment effectiveness for olanzapine and comparator atypical antipsychotics for schizophrenia. J Clin Psychopharmacol 2006; 26: 632-7.
8. Perkins DO, Gu H, Weiden PJ, et al. Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study. J Clin Psychiatry 2008; 69: 106-13.
9. Weinmann S, Janssen B, Gaebel W,. Guideline adherence in medication management of psychotic disorders: an observational multisite hospital study. Acta Psychiatr Scand 2005; 112: 18-25.